Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Matthew E. Monaghan
Age : 52
Public asset : 9,759,802 USD
Linked companies : Syneos Health, Inc. - Invacare Corporation
Presently, Matthew E. Monaghan is Chairman, President & Chief Executive Officer for Invacare Corp. and Chief Executive Officer & Director at Freedom Designs, Inc. and President & Director at Adaptive Switch Laboratories, Inc. (both are subsidiaries of Invacare Corp.).

He is also on the board of Syneos Health LLC, Cleveland Clinic Avon Lake Hospital and Syneos Health, Inc.

In his past career Matthew E. Monaghan held the position of COO & Manager-Business Development at Global Home Products LLC, Chief Operating Officer for Cerberus Capital Management LP, Manager-Business Development at General Electric Co., Senior VP-Global Hips & Reconstructive Research at Zimmer Biomet Holdings, Inc. and Chairman at CD Diagnostics, Inc. (a subsidiary of Zimmer Biomet Holdings, Inc.), Chief Transition Officer at Fenwal, Inc. and Operating Executive at TPG Capital LLC.

Matthew E. Monaghan received an MBA from INSEAD, a graduate degree from Massachusetts Institute of Technology and an undergraduate degree from Cornell University.

Current positions of Matthew E. Monaghan 
NameTitle Since
Syneos Health, Inc.
(Biotechnology & Medical Research)
Independent Director 2016
Invacare Corporation
(Medical Equipment, Supplies & Distribution)
Chairman, President & Chief Executive Officer 2015
Syneos Health LLC Independent Director 2016
Adaptive Switch Laboratories, Inc. President & Director -
Freedom Designs, Inc. Chief Executive Officer & Director -
Cleveland Clinic Avon Lake Hospital Trustee -

Holdings of Matthew E. Monaghan 
Invacare Corporation (IVC)
(Medical Equipment, Supplies & Distribution)
1,019,3462.92%8,226,122 USD
Syneos Health, Inc. (SYNH)
(Biotechnology & Medical Research)
17,1380.017%1,533,680 USD

Matthew E. Monaghan: Personal Network 
Most Read News 
07/28MARK ZUCKERBERG : Facebook's slowdown warning hangs over strong ad sales, while Zuckerberg talks 'metaverse'
07/20JEFF BEZOS : billionaire Bezos has successful suborbital jaunt
07/26JEFF BEZOS : Bezos-backed plant food firm NotCo joins unicorn club after latest funding
07/26MICHAEL KLEIN : EV maker Lucid rises in Nasdaq debut after merger with Klein-backed SPAC
07/27RAJESH KUMAR : GE warns of inflationary pressure after lifting cash flow estimate
07/26JEFF BEZOS : Bezos offers NASA $2 billion in exchange for moon mission contract
07/27IAN READ : Exclusive-Rivian ready to invest $5 billion in second U.S. assembly plant -document
07/29TREVOR MILTON : U.S. charges Nikola founder Trevor Milton with lying to investors
07/22RYAN COHEN : Flush from Reddit rally, GameStop plots store revival
07/27JIN SHI : Philippines says close to sale of former Hanjin shipyard
More news

© 2021 People and Ownership :   
Matthew E. Monaghan : Connections